Kim Rivers Sells 204,815 Shares of Trulieve Cannabis (NYSE:TRLV) Stock

Trulieve Cannabis Corp. (NYSE:TRLVGet Free Report) CEO Kim Rivers sold 204,815 shares of the firm’s stock in a transaction on Monday, June 22nd. The shares were sold at an average price of $9.35, for a total value of $1,915,020.25. Following the transaction, the chief executive officer owned 2,693,724 shares in the company, valued at approximately $25,186,319.40. This trade represents a 7.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Stock Down 5.8%

TRLV opened at $8.59 on Wednesday. Trulieve Cannabis Corp. has a 1 year low of $3.25 and a 1 year high of $13.28.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Zacks Research raised shares of Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings assumed coverage on Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating for the company. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Trulieve Cannabis currently has an average rating of “Reduce”.

Check Out Our Latest Stock Report on Trulieve Cannabis

Trulieve Cannabis Company Profile

(Get Free Report)

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.

Further Reading

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.